Will CETP inhibition survive the demise of torcetrapib? Anders G. Olsson Invited Commentary 06 April 2008 Pages: 97 - 99
Prevention and noninvasive management of coronary atherosclerosis in patients with diabetes Martial G. BourassaColin Berry OriginalPaper 06 April 2008 Pages: 106 - 116
Alcohol consumption and heart failure: A systematic review Luc DjousséJ. Michael Gaziano OriginalPaper 06 April 2008 Pages: 117 - 120
Racial and ethnic differences in hypertension Deborah S. MinorMarion R. WoffordDaniel W. Jones OriginalPaper 06 April 2008 Pages: 121 - 127
Rheumatoid arthritis and cardiovascular disease Saurabh S. DhawanArshed A. Quyyumi OriginalPaper 06 April 2008 Pages: 128 - 133
PPARγ agonists and coronary atherosclerosis Melanie S. SulistioAdrienne ZionRobert Chilton OriginalPaper 06 April 2008 Pages: 134 - 141
Adjunctive interventions in myocardial infarction: The role of statin therapy Peter H. JonesJohn A. Farmer OriginalPaper 06 April 2008 Pages: 142 - 148
Aspirin resistance in atherosclerosis Price BlairJane E. Freedman OriginalPaper 06 April 2008 Pages: 149 - 157
Intensive statin therapy in acute coronary syndromes Tze Vun LiewKausik K. Ray OriginalPaper 06 April 2008 Pages: 158 - 163
Novel markers of inflammation in atherosclerosis Salim S. ViraniVenkateshwar R. PolsaniVijay Nambi OriginalPaper 06 April 2008 Pages: 164 - 170
Proatherogenic high-density lipoprotein, vascular inflammation, and mimetic peptides Roger YuBabak YektaAbbas Ardehali OriginalPaper 06 April 2008 Pages: 171 - 176